Inhibition of cancer cell proliferation by midazolam by targeting transient receptor potential melastatin 7

Roderick HL and Cook SJ: Ca²⁺ signalling checkpoints in cancer: remodelling Ca²⁺ for cancer cell proliferation and survival. Nat Rev Cancer. 8:361–375. 2008.

Monteith GR, McAndrew D, Faddy HM and Roberts-Thomson SJ: Calcium and cancer: targeting Ca²⁺ transport. Nat Rev Cancer. 7:519–530. 2007. View Article : Google Scholar : PubMed/NCBI

Capiod T: Cell proliferation, calcium influx and calcium channels. Biochimie. 93:2075–2079. 2011. View Article : Google Scholar : PubMed/NCBI

Bödding M: TRP proteins and cancer. Cell Signal. 19:617–624. 2007.

Jiang J, Li MH, Inoue K, Chu XP, Seeds J and Xiong ZG: Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation. Cancer Res. 67:10929–10938. 2007. View Article : Google Scholar : PubMed/NCBI

Zhu W, Ou Y, Li Y, et al: A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway. Mol Pharmacol. 75:812–819. 2009. View Article : Google Scholar

Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001. View Article : Google Scholar : PubMed/NCBI

Ramsey IS, Delling M and Clapham DE: An introduction to TRP channels. Annu Rev Physiol. 68:619–647. 2006. View Article : Google Scholar : PubMed/NCBI

Carafoli E: Calcium signaling: a tale for all seasons. Proc Natl Acad Sci USA. 99:1115–1122. 2002. View Article : Google Scholar : PubMed/NCBI

Santoni G and Farfariello V: TRP channels and cancer: new targets for diagnosis and chemotherapy. Endocr Metab Immune Disord Drug Targets. 11:54–67. 2011. View Article : Google Scholar : PubMed/NCBI

Prevarskaya N, Zhang L and Barritt G: TRP channels in cancer. Biochim Biophys Acta. 1772:937–946. 2007. View Article : Google Scholar

Gao H, Chen X, Du X, Guan B, Liu Y and Zhang H: EGF enhances the migration of cancer cells by up-regulation of TRPM7. Cell Calcium. 50:559–568. 2011. View Article : Google Scholar : PubMed/NCBI

Yee NS, Zhou W and Liang IC: Transient receptor potential ion channel Trpm7 regulates exocrine pancreatic epithelial proliferation by Mg²⁺-sensitive Socs3a signaling in development and cancer. Dis Model Mech. 4:240–254. 2011. View Article : Google Scholar : PubMed/NCBI

Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H and Ouadid-Ahidouch H: Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol. 297:C493–C502. 2009. View Article : Google Scholar : PubMed/NCBI

Kahl CR and Means AR: Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev. 24:719–736. 2003. View Article : Google Scholar : PubMed/NCBI

Takuwa N, Zhou W, Kumada M and Takuwa Y: Ca(2+)-dependent stimulation of retinoblastoma gene product phosphorylation and p34cdc2 kinase activation in serum-stimulated human fibro-blasts. J Biol Chem. 268:138–145. 1993.

Tombes RM, Grant S, Westin EH and Krystal G: G1 cell cycle arrest and apoptosis are induced in NIH 3T3 cells by KN-93, an inhibitor of CaMK-II (the multifunctional Ca²⁺/CaM kinase). Cell Growth Differ. 6:1063–1070. 1995.PubMed/NCBI

Morris TA, DeLorenzo RJ and Tombes RM: CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Exp Cell Res. 240:218–227. 1998. View Article : Google Scholar : PubMed/NCBI

Ben-Eliyahu S: The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun. 17(Suppl 1): S27–S36. 2003. View Article : Google Scholar : PubMed/NCBI

Ben-Eliyahu S, Page GG, Yirmiya R and Shakhar G: Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 80:880–888. 1999. View Article : Google Scholar : PubMed/NCBI

Goldfarb Y and Ben-Eliyahu S: Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Dis. 26:99–114. 2006.PubMed/NCBI

Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E and Sessler DI: Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 105:660–664. 2006. View Article : Google Scholar : PubMed/NCBI

Melamed R, Bar-Yosef S, Shakhar G, Shakhar K and Ben-Eliyahu S: Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 97:1331–1339. 2003. View Article : Google Scholar : PubMed/NCBI

Arain MR and Buggy DJ: Anaesthesia for cancer patients. Curr Opin Anaesthesiol. 20:247–253. 2007. View Article : Google Scholar : PubMed/NCBI

Gupta K, Kshirsagar S, Chang L, Schwartz R, Law PY, Yee D and Hebbel RP: Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 62:4491–4498. 2002.PubMed/NCBI

Stepien H, Pawlikowska A and Pawlikowski M: Effects of benzodiazepines on thymus cell proliferation. Thymus. 12:117–121. 1989.PubMed/NCBI

Bruce JH, Ramirez AM, Lin L, Oracion A, Agarwal RP and Norenberg MD: Peripheral-type benzodiazepines inhibit proliferation of astrocytes in culture. Brain Res. 564:167–170. 1991. View Article : Google Scholar : PubMed/NCBI

Kletsas D, Li W, Han Z and Papadopoulos V: Peripheral-type benzodiazepine receptor (PBR) and PBR drug ligands in fibroblast and fibrosarcoma cell proliferation: role of ERK, c-Jun and ligand-activated PBR-independent pathways. Biochem Pharmacol. 67:1927–1932. 2004. View Article : Google Scholar : PubMed/NCBI

Gorman AM, O’Beirne GB, Regan CM and Williams DC: Antiproliferative action of benzodiazepines in cultured brain cells is not mediated through the peripheral-type benzodiazepine acceptor. J Neurochem. 53:849–855. 1989. View Article : Google Scholar : PubMed/NCBI